Bill Ackman Pershing Square Capital Management
Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$3.45B |
| 2 |
AGN
Allergan plc
AGN
|
+$384M |
| 3 |
Zoetis
ZTS
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$5.66B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.45% |
| 2 | Materials | 28.09% |
| 3 | Industrials | 17.01% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Real Estate | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Bausch Health
BHC
$3.11B
| $3.87B | 25.84% |
+19,473,933
| New | +$3.45B |
2015 Q1
0 quarters
|
|
2
Air Products & Chemicals
APD
$69.5B
| $3.11B | 20.77% |
22,213,551
| – | – |
2013 Q2
7 quarters
|
|
3
Canadian Pacific Kansas City
CP
$81.5B
| $2.55B | 17.01% |
69,704,450
| – | – |
2013 Q2
7 quarters
|
|
|
4
Zoetis
ZTS
$33.6B
| $1.94B | 12.93% |
41,823,145
+253,499
| +0.6% | +$11.4M |
2014 Q3
2 quarters
|
|
5
Restaurant Brands International
QSR
$26.9B
| $1.46B | 9.75% |
38,003,984
| – | – |
2014 Q4
1 quarter
|
|
6
Element Solutions
ESI
$7.89B
| $1.1B | 7.33% |
42,737,394
| – | – |
2014 Q1
4 quarters
|
|
7
Howard Hughes
HHH
$5.02B
| $553M | 3.69% |
3,742,850
| – | – |
2013 Q2
7 quarters
|
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $401M | 2.68% |
+1,348,358
| New | +$384M |
2015 Q1
0 quarters
|
|
|
AGN
9
DELISTED
Allergan Inc
AGN
| – | – |
-26,635,978
| Closed | -$5.66B | – |
|
Similar funds
Bill Ackman's Q1 2015 Portfolio in Review
As of Q1 2015, Bill Ackman held 9 positions worth $15B, down 6.7% from $16B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bill Ackman withdrew a net $1.81B in Q1 2015, closing 1 position. Its most notable exit was Allergan Inc, an estimated $5.66B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Materials and Industrials.
Against the trend, Bill Ackman opened a new position in Bausch Health worth $3.87B.
- Bill Ackman's largest Q1 2015 buy was Bausch Health: 19,473,933 shares worth $3.87B.
- Bill Ackman added most to Zoetis in Q1 2015, an estimated $11.4M increase.
- Bill Ackman fully exited Allergan Inc in Q1 2015, selling an estimated $5.66B.
- Bill Ackman's ten largest holdings make up 100% of its $15B portfolio in Q1 2015.
- Bill Ackman opened 2 new positions and closed 1 in Q1 2015.
- Bill Ackman's portfolio value fell 6.7% quarter-over-quarter to $15B.
Based on Pershing Square Capital Management's 13F filing for Q1 2015, filed 15 May 2015.